Clinical Trials
3 trialsNCT04294641 2026-01-23
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00689884 2018-04-20
Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies
Dartmouth-Hitchcock Medical Center
Phase NA Terminated
NCT00410696 2013-07-01
Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy
Istituto Clinico Humanitas
Phase 2 Completed